Personal information

Activities

Employment (7)

BC Cancer Foundation: Vancouver, CA

2024-02-07 to present | Postdoctoral Research Fellow (Terry Fox Laboratory)
Employment
Source: Self-asserted source
Amber Louwagie

Ghent University: Ghent, BE

2018-10-01 to 2023-10-09 | PhD student (Deparment of Biomoleculair Medicine)
Employment
Source: Self-asserted source
Amber Louwagie

University Children’s Hospital Basel: Basel, CH

2018-02-01 to 2018-08-15 | Master student (Childhood Leukemia Lab)
Employment
Source: Self-asserted source
Amber Louwagie

Ludwig-Maximilians-Universität München: Munich, DE

2017-10-01 to 2017-11-01 | Master student (Center for Neurodegenerative Diseases)
Employment
Source: Self-asserted source
Amber Louwagie

Ludwig-Maximilians-Universität München: Munich, DE

2017-08-01 to 2017-08-31 | Master student (Biozentrum, Cell and Developmental Biology)
Employment
Source: Self-asserted source
Amber Louwagie

Max Planck Institute of Biochemistry: Martinsried, DE

2016-10-01 to 2017-01-31 | Master student (Max Planck Institute for Biotechnology)
Employment
Source: Self-asserted source
Amber Louwagie

KU Leuven: Leuven, BE

2016-02-01 to 2016-05-31 | Bachelor student (Biochemistry, Molecular and Structural Biology Lab)
Employment
Source: Self-asserted source
Amber Louwagie

Education and qualifications (3)

Ghent University: Ghent, BE

2018-10-01 to 2023-10-09 | Doctoral degree in Health Sciences
Education
Source: Self-asserted source
Amber Louwagie

Ludwig-Maximilians-Universität München: Munich, DE

2016-09-01 to 2018-08-15 | Master Biochemistry
Education
Source: Self-asserted source
Amber Louwagie

KU Leuven: Leuven, BE

2013-09-15 to 2016-07-31 | Bachelor Biochemistry and Biotechnology
Education
Source: Self-asserted source
Amber Louwagie

Funding (2)

The role of the SOX11 lineage-specific transcription factor in regulation of SWI/SNF and PRC2 activity in adrenergic NB cells

2019-11 to 2023-10 | Grant
Fund for Scientific Research (Brussels, BE)
GRANT_NUMBER:

11B0222N

Source: Self-asserted source
Amber Louwagie

SOX11 controlled SWI/SNF combinatorial assembly and neuroblastoma super-enhancer landscaping

2018-11 to 2019-10 | Grant
Kom op tegen Kanker (Ghent, BE)
GRANT_NUMBER:

STI.VLK.2018.0016.01

Source: Self-asserted source
Amber Louwagie

Works (5)

Emerging interactions between RNA methylation and chromatin architecture

Current Opinion in Genetics & Development
2024-12 | Journal article
Contributors: Amber Louwagie; Ly P Vu
Source: check_circle
Crossref

SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry

Nature Communications
2023-03-07 | Journal article
Contributors: Bieke Decaesteker; Amber Louwagie; Siebe Loontiens; Fanny De Vloed; Sarah-Lee Bekaert; Juliette Roels; Suzanne Vanhauwaert; Sara De Brouwer; Ellen Sanders; Alla Berezovskaya et al.
Source: check_circle
Crossref

The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53

Blood
2023-02-03 | Journal article
Contributors: Maria-Riera Piqué-Borràs; Zivojin Jevtic; Frederik Otzen Bagger; Jonathan Seguin; Rathick Sivalingam; Matheus Filgueira Bezerra; Amber Louwaige; Sabine Juge; Ioannis Nellas; Robert Ivanek et al.
Source: check_circle
Crossref

RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

Science Advances
2022-07-15 | Journal article
Contributors: Carolina Nunes; Lisa Depestel; Liselot Mus; Kaylee M. Keller; Louis Delhaye; Amber Louwagie; Muhammad Rishfi; Alex Whale; Neesha Kara; Simon R. Andrews et al.
Source: check_circle
Crossref

SOX11 is a lineage-dependency factor and master epigenetic regulator in neuroblastoma

2020-08-21 | Preprint
Contributors: Bieke Decaesteker; Amber Louwagie; Siebe Loontiens; Fanny De Vloed; Juliette Roels; Suzanne Vanhauwaert; Sara De Brouwer; Ellen Sanders; Geertrui Denecker; Eva D’haene et al.
Source: check_circle
Crossref